Silverback Therapeutics I... (SBTX)
NASDAQ: SBTX
· Real-Time Price · USD
5.87
0.06 (1.03%)
At close: Nov 09, 2022, 5:00 AM
Silverback Therapeutics Revenue
Silverback Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2023, Silverback Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
90
Market Cap
550.43M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|